A detailed history of Cibc Private Wealth Group, LLC transactions in Vericel Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 740 shares of VCEL stock, worth $33,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares
740
Holding current value
$33,233
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $24,064 - $38,724
740 New
740 $38,000
Q3 2022

Nov 14, 2022

SELL
$22.62 - $32.54 $7,690 - $11,063
-340 Reduced 3.26%
10,075 $234,000
Q2 2022

Aug 03, 2022

SELL
$22.88 - $39.45 $1,372 - $2,367
-60 Reduced 0.57%
10,415 $262,000
Q1 2022

May 16, 2022

BUY
$31.69 - $43.29 $331,952 - $453,462
10,475 New
10,475 $400,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.12B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.